April 27, 2026

Today, I’m excited to share Evra Health’s beta testing white paper, which summarizes what we learned during our five-month beta period from December 1, 2025 through April 27, 2026.

Evra was created with a clear mission: to improve health for as many people as possible in an accessible, science-backed, whole-person way. Our goal is to help people connect the dots between their health data, daily habits, and personal goals, so they can take simple, meaningful actions that compound over time.

There is no shortage of health information in the world. Most people are overwhelmed by it. Lab results, wearable data, nutrition advice, sleep trends, supplement questions, exercise recommendations, and conflicting online opinions often exist in separate silos. Evra was built to bring those pieces together in a way that is practical, personalized, and grounded in evidence.

Our beta period was designed to evaluate the technology, user experience, clinical relevance, and early impact of Evra as a dynamic AI-enabled health platform.

The first month focused on model evaluation: accuracy, hallucination risk, clinical safety, and how the model performed as it was trained on our proprietary dataset in lifestyle and integrative medicine. For an AI health product, this work was foundational.

January and February were dedicated to product design, UI refinement, and feature development. We added new features, improved existing ones, and worked closely with early users to understand how Evra could become more intuitive and supportive in daily life.

From February through April, we focused more specifically on outcomes. We looked at how users engaged with the platform over time, how they responded to coaching and nudges, and how Evra could support behavior change, chronic disease prevention, and long-term health management.

One of the central challenges of evaluating Evra is that the product itself is dynamic. When a platform evolves week by week, with new features, improved design, and more refined model behavior, it is difficult to compare one time point to another in a perfectly linear way. We have tried to make our findings as clear and transparent as possible while also reflecting the reality of building a living, adaptive health platform.

At its core, Evra is designed to help people spend less time searching for answers and more time taking meaningful action. We believe the future of health will be personalized, preventative, continuous, and deeply human: powered by AI, but grounded in science, safety, and whole-person care.

We are thrilled to be launching Evra in the U.S. and India tomorrow, on April 28, 2026, followed by our global launch on May 4, 2026. This white paper marks an important milestone in that journey and reflects months of careful work by our team, thoughtful feedback from early users, and a commitment to building health technology that is innovative, trustworthy, and clinically responsible.

You can read the full white paper below.

As always, we welcome your questions, reflections, and feedback. We are grateful to everyone who has helped shape Evra so far, and we are just getting started.

Wishing you health, clarity, and momentum,

-Amitha